UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma

Frontiers in oncology, 2024, Vol.14, p.1398902

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma

Blood cancer journal (New York), 2024-05, Vol.14 (1), p.84-84, Article 84

2024

Link zum Volltext

Verfügbarkeit prüfen

The Power of a Talisman

Journal of graduate medical education, 2019-12, Vol.11 (6), p.719-719

Rajeeve, Sridevi

2019

Link zum Volltext

Verfügbarkeit prüfen

Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma: Moving Into the Spotlight

The cancer journal (Sudbury, Mass.), 2021-05, Vol.27 (3), p.205

2021

Link zum Volltext

Verfügbarkeit prüfen

Factor XI Deficiency in Pregnant Women: A Case-Series from a New York City Hospital

Blood, 2020-11, Vol.136 (Supplement 1), p.16-16

2020

Link zum Volltext

Verfügbarkeit prüfen

Acute Myeloid Leukemia and Cirrhosis: Trends in Utilization of Induction Chemotherapy, Rate of Hospitalizations and Mortality

Blood, 2019-11, Vol.134 (Supplement_1), p.3864-3864

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of denosumab on skeletal-related events in solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18754-e18754

2018

Link zum Volltext

Verfügbarkeit prüfen

How Old is Too Old for CAR-T Cell Therapies in Multiple Myeloma?

Transplantation and cellular therapy, 2023-06, Vol.29 (6), p.343-344

2023

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of Complications

Blood, 2019-11, Vol.134 (Supplement_1), p.1725-1725

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors and Trends for Incidence of Acute Coronary Syndrome after Hematopoietic Stem Cell Transplant - a 15-Year Experience with National Inpatient Sample

Blood, 2019-11, Vol.134 (Supplement_1), p.4564-4564

2019

Link zum Volltext

Verfügbarkeit prüfen

Etiologies and Predictors of 30-Day Readmission in Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.4759-4759

2019

Link zum Volltext

Verfügbarkeit prüfen

NECROTIZING FASCIITIS TRIGGERED BY TRAUMA - BUT NOT TRAUMA

Chest, 2019-10, Vol.156 (4), p.A2023-A2023

2019

Link zum Volltext

Verfügbarkeit prüfen

A real-world experience of combined treatment with romidepsin and azacitidine in patients with peripheral T-cell lymphoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e19550-e19550

2022

Link zum Volltext

Verfügbarkeit prüfen

Early detection of CRS after CAR-T therapy using wearable monitoring devices: Preliminary results in relapsed/refractory multiple myeloma (RRMM)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13626-e13626

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Rivaroxaban with Argatroban in Heparin Induced Thrombocytopenia Using Historical Controls : A Case-Control Study

Blood, 2018-11, Vol.132 (Supplement 1), p.4996-4996

2018

Link zum Volltext

Verfügbarkeit prüfen

Survival for Relapsed/Refractory Hodgkin Lymphoma Patients with Recurrent or Persistent Disease Following Autologous Hematopoietic Stem Cell Transplantation Treated in the Modern Era

Blood, 2018-11, Vol.132 (Supplement 1), p.2148-2148

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Additional Cytogenetic Abnormalities and Complex Karyotype on Event-Free Survival in Acute Promyelocytic Leukemia: Analysis from a Single Academic Center Plus the APML4 Study

Blood, 2020-11, Vol.136 (Supplement 1), p.34-35

2020

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) at Admission Are Predictors for Worse Functional Outcome in Cerebral Venous Sinus Thrombosis

Blood, 2020-11, Vol.136 (Supplement 1), p.8-9

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparing Bendamustine-Based Bridging to Standard Chemotherapy in CAR T Cell Therapy for Multiple Myeloma: An Analysis of Toxicity Profiles

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S386-S387

2024

Link zum Volltext

Verfügbarkeit prüfen

Opportunistic Infections, Is Non Hodgkin Lymphoma One of the Risk Factors for Mortality?

Blood, 2018-11, Vol.132 (Supplement 1), p.5818-5818

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Hospital Costs and in-Hospital Outcomes of Patients Admitted with Sepsis with and without Non Hodgkin Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.5817-5817

2018

Link zum Volltext

Verfügbarkeit prüfen

Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.3816-3816

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-world outcomes of brentuximab vedotin maintenance after autologous stem cell transplant in relapsed/refractory classical Hodgkin lymphoma: Is less enough?

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7514-7514

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(14)
Blood Advances
(7)
Journal Of Clinical Oncology
(5)
Transplantation And Cellular Therapy
(2)
Blood Cancer Journal
(1)
Chest
(1)
Circulation
(1)
Clinical Lymphoma, Myeloma And Leukemia
(1)
Frontiers In Oncology
(1)
Hemasphere
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma

P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma

The Power of a Talisman

Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma: Moving Into the Spotlight

Factor XI Deficiency in Pregnant Women: A Case-Series from a New York City Hospital

Acute Myeloid Leukemia and Cirrhosis: Trends in Utilization of Induction Chemotherapy, Rate of Hospitalizations and Mortality

Impact of denosumab on skeletal-related events in solid tumors

How Old is Too Old for CAR-T Cell Therapies in Multiple Myeloma?

Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of Complications

Risk Factors and Trends for Incidence of Acute Coronary Syndrome after Hematopoietic Stem Cell Transplant - a 15-Year Experience with National Inpatient Sample

Etiologies and Predictors of 30-Day Readmission in Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia

NECROTIZING FASCIITIS TRIGGERED BY TRAUMA - BUT NOT TRAUMA

A real-world experience of combined treatment with romidepsin and azacitidine in patients with peripheral T-cell lymphoma

Early detection of CRS after CAR-T therapy using wearable monitoring devices: Preliminary results in relapsed/refractory multiple myeloma (RRMM)

Comparison of Rivaroxaban with Argatroban in Heparin Induced Thrombocytopenia Using Historical Controls : A Case-Control Study

Survival for Relapsed/Refractory Hodgkin Lymphoma Patients with Recurrent or Persistent Disease Following Autologous Hematopoietic Stem Cell Transplantation Treated in the Modern Era

Impact of Additional Cytogenetic Abnormalities and Complex Karyotype on Event-Free Survival in Acute Promyelocytic Leukemia: Analysis from a Single Academic Center Plus the APML4 Study

Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) at Admission Are Predictors for Worse Functional Outcome in Cerebral Venous Sinus Thrombosis

Comparing Bendamustine-Based Bridging to Standard Chemotherapy in CAR T Cell Therapy for Multiple Myeloma: An Analysis of Toxicity Profiles

Opportunistic Infections, Is Non Hodgkin Lymphoma One of the Risk Factors for Mortality?

Comparison of Hospital Costs and in-Hospital Outcomes of Patients Admitted with Sepsis with and without Non Hodgkin Lymphoma

Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia

Real-world outcomes of brentuximab vedotin maintenance after autologous stem cell transplant in relapsed/refractory classical Hodgkin lymphoma: Is less enough?

Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the Effect of Dose on Progression Free Survival

Suchergebnisse filtern